A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/29/2006	CN1871350A Nucleic acids useful for triggering tumor cell lethality
11/29/2006	CN1871258A Fusion polypeptides, and use thereof in antivascular tumor therapy
11/29/2006	CN1871257A Interferon-beta composite
11/29/2006	CN1871255A Novel secretory protein and production process and use thereof
11/29/2006	CN1871254A Modified IL-4 mutein receptor antagonists
11/29/2006	CN1871253A Hydrochloride salts of a glycopeptide phosphonate derivative
11/29/2006	CN1871252A Method for the production of fusion proteins in transgenic mammal milk
11/29/2006	CN1871030A Method of inhibiting secretase activity
11/29/2006	CN1871024A Remedy and therapeutic method for periodontal diseases and pulpal diseases
11/29/2006	CN1871023A A teicoplanin composition with improved antibiotic activity
11/29/2006	CN1871022A Peptides and compounds that bind to a receptor
11/29/2006	CN1871021A Treating or preventing restless legs syndrome using prodrugs of GABA analogs
11/29/2006	CN1871020A Antagonistic analogs of GH-RH (2003)
11/29/2006	CN1871017A Metalloprotease activation of myostatin, and methods of modulating myostatin activity
11/29/2006	CN1870894A Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
11/29/2006	CN1870893A Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
11/29/2006	CN1869230A Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
11/29/2006	CN1869222A Rat testis high expression gene rDJL taking part in spermatozoon acrosome formation
11/29/2006	CN1869219A Sensibility of HSD11 gene capable of increasing sensibility of tumour cell to multipile withor induction factor
11/29/2006	CN1869217A Method for producing transgene protein medicine of mammary gland expression using gland virus as carrier mammary
11/29/2006	CN1869210A Purification method of human glutathione-s-transferase Pi and application of said enzyme
11/29/2006	CN1869208A Preparation of caterpillar fungus SOD and health-care product containing caterpillar fungus SOD
11/29/2006	CN1869071A Recombination immune therapeutic protein and its expression method and application
11/29/2006	CN1869068A Corticotropin releasing factor 2 receptor agonists
11/29/2006	CN1869066A Tumour antigen protein and tumour antigen peptide
11/29/2006	CN1869064A Tumour antigen protein and tumour antigen peptide
11/29/2006	CN1869063A Preparation method of polypeptide for inhibiting gelatin enzyme A activity and its application
11/29/2006	CN1869062A Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application
11/29/2006	CN1869061A Peptidomimetic protease inhibitors
11/29/2006	CN1868553A Cervical skin tissue engineering stent and its making method
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1868543A Biodegradable high molecular gel medicine composition, its prepn. method and use thereof
11/29/2006	CN1868538A Composition contg. scorpion protein and SOD used as food and medicine
11/29/2006	CN1868537A Therapeutic effect of type II collagen allosteric peptide for treating rheumatoid arthritis
11/29/2006	CN1868536A Use of cell cycle regulation protein Cyclin B1 for preparing medicine for anti-human esophagus cancer invasion and transference
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1286976C Interferon-alpha/beta binding protein, its preparation and use
11/29/2006	CN1286975C High affinity immunoglobulin for human antigen and heterologous tumour for manufacturing thereof
11/29/2006	CN1286974C Mutant of recombined glucokinase for anti blood platelet collecting and low immunogenic
11/29/2006	CN1286847C Separation of cresol from mare's urine
11/29/2006	CN1286530C Self-regulated apoptosis of inflammatory cells by gene therapy
11/29/2006	CN1286525C New type pellicle of ocean lysozyme and preparation method
11/29/2006	CN1286524C Use of OPN for treatment and/or prevention of neurological diseases
11/29/2006	CN1286472C Method for obtaining estrogens from mare's urine
11/29/2006	CN1286453C Method for stablizing protein medicine and its application in microball preparation
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141662 Diagnosis using antibodies; culture product
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141652 Antibodies to PRO1561 polypeptide
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141650 Polypeptide useful in screening of agents for improving insulin resistance and glucose metabolism; receptor binding assays; skeletal muscle protein
11/28/2006	US7141649 Detection of agents which bind arrestin polypeptide; provide purified arrestin polypeptide, incubate with test a gent, detect preferential binding of test agent arrestin polypeptide
11/28/2006	US7141648 Synthesis of cyclosporin analogs
11/28/2006	US7141610 Using glycol ether to detach retinal tissue
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	US7141603 Ketospirocyclopropaneindene compounds; anticarcinogenic agents
11/28/2006	US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006	US7141594 inhibitors of HIV protease for treating AIDS
11/28/2006	US7141589 Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141552 Use of lipid conjugates in the treatment of diseases
11/28/2006	US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules
11/28/2006	US7141549 For diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins (SEC and NOV)
11/28/2006	US7141548 controlling dietetic fats and,or antilipemic agents ; reducing blood lipid concentration
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141546 CRFR2 selective ligands
11/28/2006	US7141545 Osteoarthritis, and trauma-related cartilage injuries using insulin-like growth factor I (IGF-I) is provided. The method comprises increasing the amount of IGF-I at the diseased or injured articular site to a therapeutically effective level
11/28/2006	US7141544 administering biologically active protein and a peptide stabilizer
11/28/2006	US7141542 Biologically active protein useful for aerosol delivery to the respiratory tract
11/28/2006	US7141541 Use of peptides
11/28/2006	US7141540 Used as bioactive agent carriers for drug delivery of paclitaxel
11/28/2006	US7141434 Utilizing an adenosine kinase as a surrogate analyte; methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts
11/28/2006	US7141428 Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
11/28/2006	US7141427 Regulatory element from a sugarcane proline rich protein and uses thereof
11/28/2006	US7141421 Control of metabolism with human 2-oxoglutarate carrier
11/28/2006	US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments
11/28/2006	US7141404 Candida kefyr cytosine deaminase
11/28/2006	US7141393 Interleukin-18-receptor proteins
11/28/2006	US7141392 Latent fusion protein
11/28/2006	US7141391 Monkey and canine melanin concentrating hormone receptors
11/28/2006	US7141383 EDG8 receptor, its preparation and use
11/28/2006	US7141381 Human leucine-rich repeat-containing proteins specifically expressed in the nervous system
11/28/2006	US7141379 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs
11/28/2006	US7141375 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006	US7141244 Helicobacter pylori proteins useful for vaccines and diagnostics
11/28/2006	US7141241 Use of bacterial phage associated lysing enzymes for treating upper respiratory illnesses
11/28/2006	US7141240 Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
11/28/2006	US7141239 Growth/differentiation factor of the TGF-β family
11/28/2006	CA2208095C Generation of human insulin
11/28/2006	CA2178984C Novel antibody compositions for preparing enriched human hematopoietic cell preparations
11/28/2006	CA2167525C Fungicidal methods and compositions for killing yeast and sporular microorganisms
11/28/2006	CA2035888C Nucleic acid coding for human testicular angiotensin (eca) conversion enzyme, its applications, in particular for in vitro screening of this enzyme in the organism
11/28/2006	CA2026915C Stem cell factor
11/28/2006	CA1341516C Preparation of factor x111a by gene manipulation
11/23/2006	WO2006125171A2 Lumican proteoglycan in the diagnosis and treatment of atherosclerosis
11/23/2006	WO2006125077A2 Non-natural chemokine receptor ligands and methods of use thereof
11/23/2006	WO2006125049A2 Elastin producing fibroblasts
11/23/2006	WO2006124892A2 Modulators of alpha-synuclein toxicity

1 ... 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 ... 3163